{"id":32969,"date":"2025-05-07T14:13:20","date_gmt":"2025-05-07T06:13:20","guid":{"rendered":"https:\/\/flcube.com\/?p=32969"},"modified":"2025-05-07T14:13:21","modified_gmt":"2025-05-07T06:13:21","slug":"chinas-nmpa-releases-draft-guidelines-for-development-risk-management-plan","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=32969","title":{"rendered":"China&#8217;s NMPA Releases Draft Guidelines for Development Risk Management Plan"},"content":{"rendered":"\n<p>The Center for Drug Evaluation (CDE) of China\u2019s National Medical Products Administration (NMPA) released the \u201cTechnical Guidelines for Development Risk Management Plan (draft proposal)\u201d, soliciting public feedback for one month. The guidelines aim to assist applicants in assessing clinical trial risks in a timely manner, implementing necessary control measures, and strictly enforcing drug safety responsibilities.<\/p>\n\n\n\n<p><strong>Purpose of DRMP<\/strong><br>The drafting and continuous updating of the Development Risk Management Plan (DRMP) help applicants evaluate clinical trial risks promptly and take necessary control measures. Regulatory bodies can quickly obtain information on the applicant&#8217;s risk identification and control measures through the DRMP, and assess whether the control measures are sufficient.<\/p>\n\n\n\n<p><strong>Content of the Guidelines<\/strong><br>The document consists of five chapters, providing a detailed introduction to the principles, general considerations, and main content of DRMP writing for innovative drugs. Templates are also provided for reference during writing, including an overview of drug basic information, safety, drug vigilance activities, and risk control measures. Applicants can choose to write the DRMP based on active ingredients (traditional Chinese medicine based on prescription), indications, or clinical trials according to the characteristics of the investigational drug and internal management status.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/\u300a\u521b\u65b0\u836f\u7814\u53d1\u671f\u95f4\u98ce\u9669\u7ba1\u7406\u8ba1\u5212\u64b0\u5199\u6280\u672f\u6307\u5bfc\u539f\u5219\uff08\u5f81\u6c42\u610f\u89c1\u7a3f\uff09\u300b.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of \u300a\u521b\u65b0\u836f\u7814\u53d1\u671f\u95f4\u98ce\u9669\u7ba1\u7406\u8ba1\u5212\u64b0\u5199\u6280\u672f\u6307\u5bfc\u539f\u5219\uff08\u5f81\u6c42\u610f\u89c1\u7a3f\uff09\u300b.\"><\/object><a id=\"wp-block-file--media-d4c8353d-7ca5-4596-80be-739d09c23850\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/\u300a\u521b\u65b0\u836f\u7814\u53d1\u671f\u95f4\u98ce\u9669\u7ba1\u7406\u8ba1\u5212\u64b0\u5199\u6280\u672f\u6307\u5bfc\u539f\u5219\uff08\u5f81\u6c42\u610f\u89c1\u7a3f\uff09\u300b.pdf\">\u300a\u521b\u65b0\u836f\u7814\u53d1\u671f\u95f4\u98ce\u9669\u7ba1\u7406\u8ba1\u5212\u64b0\u5199\u6280\u672f\u6307\u5bfc\u539f\u5219\uff08\u5f81\u6c42\u610f\u89c1\u7a3f\uff09\u300b<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/\u300a\u521b\u65b0\u836f\u7814\u53d1\u671f\u95f4\u98ce\u9669\u7ba1\u7406\u8ba1\u5212\u64b0\u5199\u6280\u672f\u6307\u5bfc\u539f\u5219\uff08\u5f81\u6c42\u610f\u89c1\u7a3f\uff09\u300b.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-d4c8353d-7ca5-4596-80be-739d09c23850\">Download<\/a><\/div>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/\u300a\u521b\u65b0\u836f\u7814\u53d1\u671f\u95f4\u98ce\u9669\u7ba1\u7406\u8ba1\u5212\u64b0\u5199\u6280\u672f\u6307\u5bfc\u539f\u5219\uff08\u5f81\u6c42\u610f\u89c1\u7a3f\uff09\u300b\u8d77\u8349\u8bf4\u660e.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of \u300a\u521b\u65b0\u836f\u7814\u53d1\u671f\u95f4\u98ce\u9669\u7ba1\u7406\u8ba1\u5212\u64b0\u5199\u6280\u672f\u6307\u5bfc\u539f\u5219\uff08\u5f81\u6c42\u610f\u89c1\u7a3f\uff09\u300b\u8d77\u8349\u8bf4\u660e.\"><\/object><a id=\"wp-block-file--media-37e0fee5-d7f0-4621-95e8-9ce5c204a025\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/\u300a\u521b\u65b0\u836f\u7814\u53d1\u671f\u95f4\u98ce\u9669\u7ba1\u7406\u8ba1\u5212\u64b0\u5199\u6280\u672f\u6307\u5bfc\u539f\u5219\uff08\u5f81\u6c42\u610f\u89c1\u7a3f\uff09\u300b\u8d77\u8349\u8bf4\u660e.pdf\">\u300a\u521b\u65b0\u836f\u7814\u53d1\u671f\u95f4\u98ce\u9669\u7ba1\u7406\u8ba1\u5212\u64b0\u5199\u6280\u672f\u6307\u5bfc\u539f\u5219\uff08\u5f81\u6c42\u610f\u89c1\u7a3f\uff09\u300b\u8d77\u8349\u8bf4\u660e<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/\u300a\u521b\u65b0\u836f\u7814\u53d1\u671f\u95f4\u98ce\u9669\u7ba1\u7406\u8ba1\u5212\u64b0\u5199\u6280\u672f\u6307\u5bfc\u539f\u5219\uff08\u5f81\u6c42\u610f\u89c1\u7a3f\uff09\u300b\u8d77\u8349\u8bf4\u660e.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-37e0fee5-d7f0-4621-95e8-9ce5c204a025\">Download<\/a><\/div>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-d6e12aac-a0f6-46b0-a2b2-628d77516373\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/\u300a\u521b\u65b0\u836f\u7814\u53d1\u671f\u95f4\u98ce\u9669\u7ba1\u7406\u8ba1\u5212\u64b0\u5199\u6280\u672f\u6307\u5bfc\u539f\u5219\uff08\u5f81\u6c42\u610f\u89c1\u7a3f\uff09\u300b\u5f81\u6c42\u610f\u89c1\u53cd\u9988\u8868.docx\">\u300a\u521b\u65b0\u836f\u7814\u53d1\u671f\u95f4\u98ce\u9669\u7ba1\u7406\u8ba1\u5212\u64b0\u5199\u6280\u672f\u6307\u5bfc\u539f\u5219\uff08\u5f81\u6c42\u610f\u89c1\u7a3f\uff09\u300b\u5f81\u6c42\u610f\u89c1\u53cd\u9988\u8868<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/\u300a\u521b\u65b0\u836f\u7814\u53d1\u671f\u95f4\u98ce\u9669\u7ba1\u7406\u8ba1\u5212\u64b0\u5199\u6280\u672f\u6307\u5bfc\u539f\u5219\uff08\u5f81\u6c42\u610f\u89c1\u7a3f\uff09\u300b\u5f81\u6c42\u610f\u89c1\u53cd\u9988\u8868.docx\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-d6e12aac-a0f6-46b0-a2b2-628d77516373\">Download<\/a><\/div>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Center for Drug Evaluation (CDE) of China\u2019s National Medical Products Administration (NMPA) released the&#8230;<\/p>\n","protected":false},"author":1,"featured_media":32974,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[102,14],"class_list":["post-32969","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-policy-regulatory","tag-cde","tag-nmpa"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>China&#039;s NMPA Releases Draft Guidelines for Development Risk Management Plan - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The Center for Drug Evaluation (CDE) of China\u2019s National Medical Products Administration (NMPA) released the \u201cTechnical Guidelines for Development Risk Management Plan (draft proposal)\u201d, soliciting public feedback for one month. The guidelines aim to assist applicants in assessing clinical trial risks in a timely manner, implementing necessary control measures, and strictly enforcing drug safety responsibilities.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=32969\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China&#039;s NMPA Releases Draft Guidelines for Development Risk Management Plan\" \/>\n<meta property=\"og:description\" content=\"The Center for Drug Evaluation (CDE) of China\u2019s National Medical Products Administration (NMPA) released the \u201cTechnical Guidelines for Development Risk Management Plan (draft proposal)\u201d, soliciting public feedback for one month. The guidelines aim to assist applicants in assessing clinical trial risks in a timely manner, implementing necessary control measures, and strictly enforcing drug safety responsibilities.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=32969\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-07T06:13:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-07T06:13:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/0710.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32969#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32969\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"China&#8217;s NMPA Releases Draft Guidelines for Development Risk Management Plan\",\"datePublished\":\"2025-05-07T06:13:20+00:00\",\"dateModified\":\"2025-05-07T06:13:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32969\"},\"wordCount\":211,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32969#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/0710.webp\",\"keywords\":[\"CDE\",\"NMPA\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=32969#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32969\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=32969\",\"name\":\"China's NMPA Releases Draft Guidelines for Development Risk Management Plan - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32969#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32969#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/0710.webp\",\"datePublished\":\"2025-05-07T06:13:20+00:00\",\"dateModified\":\"2025-05-07T06:13:21+00:00\",\"description\":\"The Center for Drug Evaluation (CDE) of China\u2019s National Medical Products Administration (NMPA) released the \u201cTechnical Guidelines for Development Risk Management Plan (draft proposal)\u201d, soliciting public feedback for one month. The guidelines aim to assist applicants in assessing clinical trial risks in a timely manner, implementing necessary control measures, and strictly enforcing drug safety responsibilities.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32969#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=32969\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32969#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/0710.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/0710.webp\",\"width\":1080,\"height\":608,\"caption\":\"China's NMPA Releases Draft Guidelines for Development Risk Management Plan\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32969#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"China&#8217;s NMPA Releases Draft Guidelines for Development Risk Management Plan\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"China's NMPA Releases Draft Guidelines for Development Risk Management Plan - Insight, China&#039;s Pharmaceutical Industry","description":"The Center for Drug Evaluation (CDE) of China\u2019s National Medical Products Administration (NMPA) released the \u201cTechnical Guidelines for Development Risk Management Plan (draft proposal)\u201d, soliciting public feedback for one month. The guidelines aim to assist applicants in assessing clinical trial risks in a timely manner, implementing necessary control measures, and strictly enforcing drug safety responsibilities.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=32969","og_locale":"en_US","og_type":"article","og_title":"China's NMPA Releases Draft Guidelines for Development Risk Management Plan","og_description":"The Center for Drug Evaluation (CDE) of China\u2019s National Medical Products Administration (NMPA) released the \u201cTechnical Guidelines for Development Risk Management Plan (draft proposal)\u201d, soliciting public feedback for one month. The guidelines aim to assist applicants in assessing clinical trial risks in a timely manner, implementing necessary control measures, and strictly enforcing drug safety responsibilities.","og_url":"https:\/\/flcube.com\/?p=32969","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-05-07T06:13:20+00:00","article_modified_time":"2025-05-07T06:13:21+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/0710.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=32969#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=32969"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"China&#8217;s NMPA Releases Draft Guidelines for Development Risk Management Plan","datePublished":"2025-05-07T06:13:20+00:00","dateModified":"2025-05-07T06:13:21+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=32969"},"wordCount":211,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=32969#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/0710.webp","keywords":["CDE","NMPA"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=32969#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=32969","url":"https:\/\/flcube.com\/?p=32969","name":"China's NMPA Releases Draft Guidelines for Development Risk Management Plan - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=32969#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=32969#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/0710.webp","datePublished":"2025-05-07T06:13:20+00:00","dateModified":"2025-05-07T06:13:21+00:00","description":"The Center for Drug Evaluation (CDE) of China\u2019s National Medical Products Administration (NMPA) released the \u201cTechnical Guidelines for Development Risk Management Plan (draft proposal)\u201d, soliciting public feedback for one month. The guidelines aim to assist applicants in assessing clinical trial risks in a timely manner, implementing necessary control measures, and strictly enforcing drug safety responsibilities.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=32969#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=32969"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=32969#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/0710.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/0710.webp","width":1080,"height":608,"caption":"China's NMPA Releases Draft Guidelines for Development Risk Management Plan"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=32969#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"China&#8217;s NMPA Releases Draft Guidelines for Development Risk Management Plan"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/0710.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/32969","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=32969"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/32969\/revisions"}],"predecessor-version":[{"id":32975,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/32969\/revisions\/32975"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/32974"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=32969"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=32969"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=32969"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}